CFO4Life Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $611K | Sell |
3,291
-20
| -0.6% | -$3.71K | 0.1% | 111 |
|
|
2025
Q1 | $694K | Buy |
3,311
+114
| +4% | +$23.9K | 0.12% | 89 |
|
|
2024
Q4 | $568K | Buy |
3,197
+212
| +7% | +$37.7K | 0.1% | 110 |
|
|
2024
Q3 | $589K | Buy |
2,985
+100
| +3% | +$19.7K | 0.1% | 109 |
|
|
2024
Q2 | $495K | Sell |
2,885
-23
| -0.8% | -$3.95K | 0.09% | 114 |
|
|
2024
Q1 | $530K | Sell |
2,908
-252
| -8% | -$45.9K | 0.1% | 111 |
|
|
2023
Q4 | $490K | Sell |
3,160
-691
| -18% | -$107K | 0.09% | 111 |
|
|
2023
Q3 | $574K | Buy |
3,851
+93
| +2% | +$13.9K | 0.13% | 92 |
|
|
2023
Q2 | $506K | Sell |
3,758
-456
| -11% | -$61.4K | 0.11% | 102 |
|
|
2023
Q1 | $672K | Sell |
4,214
-201
| -5% | -$32K | 0.15% | 76 |
|
|
2022
Q4 | $713K | Buy |
4,415
+483
| +12% | +$78.1K | 0.15% | 76 |
|
|
2022
Q3 | $528K | Sell |
3,932
-788
| -17% | -$106K | 0.14% | 80 |
|
|
2022
Q2 | $706K | Buy |
4,720
+161
| +4% | +$24.1K | 0.18% | 60 |
|
|
2022
Q1 | $739K | Buy |
4,559
+178
| +4% | +$28.9K | 0.16% | 66 |
|
|
2021
Q4 | $593K | Buy |
4,381
+1,564
| +56% | +$212K | 0.12% | 88 |
|
|
2021
Q3 | $304K | Hold |
2,817
| – | – | 0.07% | 110 |
|
|
2021
Q2 | $317K | Sell |
2,817
-367
| -12% | -$41.3K | 0.07% | 107 |
|
|
2021
Q1 | $345K | Sell |
3,184
-103
| -3% | -$11.2K | 0.09% | 112 |
|
|
2020
Q4 | $352K | Buy |
+3,287
| New | +$352K | 0.1% | 107 |
|
|
2020
Q1 | – | Sell |
-2,489
| Closed | -$220K | – | 118 |
|
|
2019
Q4 | $220K | Buy |
+2,489
| New | +$220K | 0.09% | 113 |
|